Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-19-003520
Filing Date
2019-03-04
Accepted
2019-03-04 16:22:07
Documents
1
Period of Report
2019-02-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2154
  Complete submission text file 0001213900-19-003520.txt   3473
Mailing Address 20 WEST 64TH STREET APT 18RS NEW YORK NY 10023
Business Address
AHERN JAMES P. (Reporting) CIK: 0001660812 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38803 | Film No.: 19654035

Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Issuer) CIK: 0001711786 (see all company filings)

EIN.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations